John M. Leonard - Articles and news items

Abbott logo
Biogen Idec logo

Biogen Idec and Abbott present positive data for Daclizumab HYP from Select Phase 2b trial at ECTRIMS/ACTRIMS

Industry news, News / 22 October 2011 / Biogen Idec

Biogen Idec and Abbott announced additional results from the SELECT Phase 2b trial…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+